These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30766849)

  • 1. Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies - Experience in tertiary care oncology center in India.
    Bhargavi V; Subbanna I; Kallur KG; Patel A; Swamy S; Patil S
    South Asian J Cancer; 2019; 8(1):31-34. PubMed ID: 30766849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Radioembolization (TARE) with
    Patel A; Subbanna I; Bhargavi V; Swamy S; Kallur KG; Patil S
    South Asian J Cancer; 2021 Apr; 10(2):81-86. PubMed ID: 34568220
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study.
    Kobe A; Zgraggen J; Messmer F; Puippe G; Sartoretti T; Alkadhi H; Pfammatter T; Mannil M
    Eur J Radiol Open; 2021; 8():100375. PubMed ID: 34485629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver.
    Orwat KP; Beckham TH; Cooper SL; Ashenafi MS; Anderson MB; Guimaraes M; Yamada R; Marshall DT
    J Gastrointest Oncol; 2017 Dec; 8(6):1072-1078. PubMed ID: 29299369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases.
    Morsbach F; Pfammatter T; Reiner CS; Fischer MA; Sah BR; Winklhofer S; Klotz E; Frauenfelder T; Knuth A; Seifert B; Schaefer N; Alkadhi H
    Invest Radiol; 2013 Nov; 48(11):787-94. PubMed ID: 23748229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.
    Barakat E; Bibok A; Rishi A; Ahmed A; Frakes JM; Hoffe SE; Armaghani AJ; Soyano AE; Costa RLB; El-Haddad G; Choi J; Kis B
    Adv Radiat Oncol; 2022; 7(1):100838. PubMed ID: 35071835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.
    She WH; Cheung TT; Yau TC; Chan AC; Chok KS; Chu FS; Liu RK; Poon RT; Chan SC; Fan ST; Lo CM
    Hepatobiliary Surg Nutr; 2014 Aug; 3(4):185-93. PubMed ID: 25202695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated radioembolization in advanced liver cancer.
    Masthoff M; Schindler P; Harders F; Heindel W; Wilms C; Schmidt HH; Pascher A; Stegger L; Rahbar K; Wildgruber M; Köhler M
    Ann Transl Med; 2020 Sep; 8(17):1055. PubMed ID: 33145274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma.
    Schelhorn J; Richly H; Ruhlmann M; Lauenstein TC; Theysohn JM
    Acta Radiol Open; 2015 Apr; 4(4):2047981615570417. PubMed ID: 25922690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
    Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
    Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases.
    Jia Z; Paz-Fumagalli R; Frey GT; Sella DM; McKinney JM; Wang W
    Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):899-905. PubMed ID: 31104533
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.
    Tomozawa Y; Jahangiri Y; Pathak P; Kolbeck KJ; Schenning RC; Kaufman JA; Farsad K
    J Vasc Interv Radiol; 2018 Jun; 29(6):858-865. PubMed ID: 29724520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children.
    Aguado A; Ristagno R; Towbin AJ; Gupta A; Haberle S; Qi Z; Patel MN; Kukreja KU; Tiao GM; Geller JI
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27510. PubMed ID: 30406959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
    Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [
    Josefsson A; Cortez AG; Rajkumar H; Latoche JD; Jaswal AP; Day KE; Zarisfi M; Rigatti LH; Huang Z; Nedrow JR
    EJNMMI Radiopharm Chem; 2023 Aug; 8(1):19. PubMed ID: 37578558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Bibok A; Mhaskar R; Jain R; Zhang J; Frakes J; Hoffe S; El-Haddad G; Parikh N; Ahmed A; Fishman MN; Choi J; Kis B
    Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1755-1762. PubMed ID: 34312688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.